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Summary
Background: An increased homocysteine (Hcy) concentration may represent a metabolic marker of folate and vitamin B 12 deficiency, both significant public health problems. For different reasons, patients with chronic obstructive pulmonary disease (COPD) are prone to these deficiencies. The study evaluates the reliability of Hcy concentration in predicting folate or vitamin B 12 deficiency in these patients. Methods: A group of 50 COPD patients (28 males/22 females, age (x ⎯ ±SD=49.0±14.5) years was enrolled. A chemiluminescent microparticle immunoassay was applied for homocysteine, folate and vitamin B 12 
Introduction
Folate is essential for »one carbon units' metabolism«, which generates intermediates necessary for nucleic acid synthesis and methylation of various biomolecules (1) . Vitamin B 12 is required as the coenzyme to methylmalonyl-CoA mutase (EC 5.4.99.2) and methionine synthase (EC 2.1.1.13), whereby the second enzyme links the metabolism of these two »B complex« vitamins (2) . It catalyzes the conversion of homo cysteine (Hcy) to methionine (Met) by virtue of a methyl group transfer from the methyltetrahydrofolate. Deficiency of either vitamin can slow the reaction and lead to deficient DNA synthesis, hyperhomocysteinemia (HHcy) and compromised methylation potential (3).
World Health Organization (WHO) estimated that folate and vitamin B 12 deficiencies could be encountered in millions of people throughout various populations (3) (4) (5) . Either of them may occur in subclinical form, when vitamin depletion can be indicated only through laboratory tests, and severe form in which clinical symptoms become overt (3). In a majority of cases, macrocytic anemia can be attributed to severe folate and vitamin B 12 deficiencies (6) . A strong causative relation has been established between severe folate deficiency and neural tube defects, adverse pregnancy outcomes, cognitive disorders in elderly etc. Severe deficiency of vitamin B 12 is evidenced as a significant risk factor for developmental delay in childhood, neuropathy in adults and memory and cognitive impairments in all ages (4, 7) . Although associated with cardiovascular disease, cancers and osteoporosis, the significance of subclinical deficiencies is still not reliably evaluated (5, 8) . Inadequate folate intake is usually responsible for folate deficiency and malabsorption for vitamin B 12 deficiency (5).
Reliable laboratory assessment of folate and vitamin B 12 status is necessary to detect a deficiency, develop a strategy for supplementation and monitor its efficacy. Folate status is usually evaluated through measurement of the folate concentration in serum/plasma, indicating dietary intake, or erythrocytes, reflecting long-term status. Vitamin B 12 concentrations in serum/plasma are considered a screening test in suspected deficiency, with holotranscobalamin measurement being recommended to improve sensitivity (5) . The utilization of metabolic markers in assessment has been recommended by the WHO since 2005 (6) . HHcy may serve as an indicator of both deficiencies. An increased level of methylmalonic acid is specific for vitamin B 12 deficiency, while the fraction of »unmetabolized folic acid« might also be associated with impairment in the pathways depending on both vitamins (3, 5) . The initially proposed cut-off values for the general population, based upon the occurrence of HHcy (defined as a Hcy concentration above 10 or 12 mmol/L) as an indicator of vitamin depletion, have undergone significant changes. For folate, 4.0 mg/L (4) was increased to 6.6 mg/L (3, 9, 10) or even 8.0 mg/L (11), while to consider vitamin B 12 status as inadequate, cut-offs of 203 ng/L (3, 4) and 473 ng/L (9, 10) were used.
Patients with chronic obstructive pulmonary disease (COPD) are evidenced to be prone to folate and vitamin B 12 deficiency, supposedly due to the severe nutritional impairments like increased basal meta bolic rate, altered caloric intake, decreased body mass index accompanied with skeletal muscle loss. Furthermore, in certain populations an inverse relationship between folate food intake and COPD risk was observed. In studies investigating HHcy in these patients the relationship between Hcy concentration and vitamin intake or blood correlation was evaluated. Nevertheless, the ability of HHcy occurrence to predict folate or vitamin B 12 deficiency was not addressed (12) (13) (14) (15) .
The study aims to provide an initial insight into the reliability of Hcy concentration mea surement in COPD patients for the purpose of detecting folate or vitamin B 12 deficiency. To achieve this, vitamin levels in this group were correlated with the Hcy concentration as well as with age and gender, the major phy siological Hcy determinants (16 , New York, USA). Deficiencies of both vitamins were defined using the abovementioned different cut-offs from the literature. To test the possibility that these may be predicted by the occurrence of HHcy, ROC analyses were performed for HHcy defined as a Hcy concentration above 10, 12 and 15 mmol/L. These cut-offs were chosen because they are applied to distinguish tolerable from increased Hcy concentrations (19) . P values below 0.05 were considered statistically significant.
Results
The Gaussian mode of distribution was observed for folate (P=0.200) and vitamin B 12 (P=0.200), while this was not the case for Hcy (P=0.041). The following concentrations (mean (SD) /median (Q1-Q3)) were measured in patients enrolled: folate 4.13 (2.16) mg/L, vitamin B 12 463.6 (271.0) ng/L, and Hcy 13.22 (11.48-16 .08) mmol/L. Correlation analyses of the variables investigated (Table I ) revealed an inverse relationship between vitamin B 12 and Hcy concentration as the only one significant. Gender associated differences in concentration ( Figure 1) were not of significance for either vitamin. Correlation between patients' age and vitamin concentration was characterized with the R=0.279 (P=0.047) for folate and R=-0.103 (P=0.477) in case of vitamin B 12 .
The calculated incidence of folate and vitamin B 12 deficiencies differed significantly (P=0.000 and P<0.000 for folate and vitamin B 12 respectively), depending on which cut-off was used for classification (Table II) .
ROC analyses failed to show any significance of HHcy (defined by various Hcy concentrations which should be exceeded) as a predictor of folate or vitamin B 12 deficiency, regardless of the cut-off used to define vitamin deficiency. Tables III and IV contain details about the ROC analysis for folate and vitamin B 12 deficiency, respectively.
Discussion
In the COPD patients enrolled, an inverse relationship between the concentrations of vitamins and Hcy was significant only for vitamin B 12 . This finding is opposite to the one reported on the basis of values measured in a group of Italian patients (15) and partially concordant with the results in a group of patients from North America in whom no significant association was observed between HHcy and these vitamins' intake as estimated from a food frequency questionnaire (14) . Although higher concentrations of folate were observed in healthy women (6, 10), gender related differences in COPD patients were not evaluated previously. Results from this study indicate that male and female patients have comparable values of both vitamins. Furthermore, a positive correlation between folate (6, 10) and vitamin B 12 (10) levels and age was shown in a healthy population. However, only a borderline significant correlation with folate was confirmed in this study.
Average folate and vitamin B 12 concentrations in this study were lower than those measured in a group of Swedish patients (7.0 mg/L and 540.0 ng/L for folate and vitamin B 12 respectively) (12) and higher in comparison with Italian patients (2.5 mg/L and 324.5 ng/L) (15) . Nevertheless, significant caution is recommended when interpreting these differences. Elderly patients were enrolled in the Swedish study and information about the methods applied for measurement was not included in the article reporting the results. In the study conducted in Italy, although the concentrations were also measured using CMIA, only patients with no COPD exacerbations 6 months prior to blood sampling were included.
Prevalence of deficiency in the present study was highly dependent on the cut-off values used. In the case of folate, it increased from 32.3%, when defined with the cut-off of 4.0 mg/L, to 84.0% or even 90.0% with the cut-off set at 6.6 mg/L and 8.0 mg/L respectively. For vitamin B 12 , the change of cut-off from 203 ng/L to 473 ng/L was accompanied by an increase in the percentage of patients considered deficient from 4.0% to 58.0%. To consider Swedish (20) . Despite the fact that this Hcy influx might be regarded as an epiphenomenon in COPD, not influenced by any traditional determinant of Hcy concentration (20) , certain attention should be focused on the molecular and cellular oxidative damage caused by HHcy (21) . Taken together with the report about the presence of increased oxidative stress at the moment of remission accomplishment after COPD exacerbation (22) , it can be assumed that a certain time span is needed for the vitamins' depletion, predictable by HHcy, to develop in these patients.
A rather small number of participants is a limitation of the present study. Although the other studies addressing »B-vitamins complex« deficiency and its relationship with the Hcy level included a comparable number of patients, the results presented should be interpreted as »pilot« and further evaluation of their confidence in larger studies is recommended.
The results presented support the conclusion that the reliability of Hcy concentration as a biomarker of folate or vitamin B 12 depletion in COPD is not satisfactory and that their deficiency cannot be predicted by the occurrence of HHcy.
